Folger Nolan Fleming Douglas Capital Management’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.4M Sell
29,919
-202
-0.7% -$74.9K 1.02% 29
2026
Q1
$8.15M Sell
30,121
-143
-0.5% -$42.6K 0.73% 37
2025
Q4
$9.99M Sell
30,264
-291
-1% -$98.6K 1.02% 26
2025
Q3
$10.6M Buy
30,555
+1,757
+6% +$531K 1.1% 24
2025
Q2
$8.98M Buy
28,798
+3,660
+15% +$1.4M 1% 27
2025
Q1
$13.2M Sell
25,138
-85
-0.3% -$43.5K 1.48% 19
2024
Q4
$12.8M Buy
25,223
+432
+2% +$245K 1.34% 19
2024
Q3
$14.5M Buy
24,791
+287
+1% +$162K 1.43% 19
2024
Q2
$12.5M Buy
24,504
+484
+2% +$237K 1.28% 21
2024
Q1
$11.9M Buy
24,020
+241
+1% +$123K 1.21% 22
2023
Q4
$12.5M Sell
23,779
-247
-1% -$132K 1.37% 20
2023
Q3
$12.1M Buy
24,026
+297
+1% +$146K 1.41% 19
2023
Q2
$11.4M Buy
23,729
+928
+4% +$454K 1.24% 22
2023
Q1
$10.8M Buy
22,801
+157
+0.7% +$75.8K 1.26% 22
2022
Q4
$12M Buy
22,644
+26
+0.1% +$13.8K 1.44% 18
2022
Q3
$11.4M Sell
22,618
-173
-0.8% -$91K 1.55% 16
2022
Q2
$11.7M Sell
22,791
-247
-1% -$124K 1.54% 16
2022
Q1
$11.7M Sell
23,038
-41
-0.2% -$19.8K 1.31% 22
2021
Q4
$11.6M Sell
23,079
-15
-0.1% -$6.79K 1.26% 22
2021
Q3
$9.02M Sell
23,094
-87
-0.4% -$36K 1.09% 27
2021
Q2
$9.28M Sell
23,181
-9
-0% -$3.59K 1.08% 25
2021
Q1
$8.63M Sell
23,190
-213
-0.9% -$73.8K 1.05% 26
2020
Q4
$8.21M Buy
23,403
+156
+0.7% +$52.3K 1.08% 24
2020
Q3
$7.25M Sell
23,247
-174
-0.7% -$53.4K 1.09% 24
2020
Q2
$6.91M Sell
23,421
-145
-0.6% -$41.5K 1.12% 24
2020
Q1
$5.88M Sell
23,566
-715
-3% -$197K 1.17% 25
2019
Q4
$7.14M Sell
24,281
-87
-0.4% -$22.8K 1.04% 28
2019
Q3
$5.3M Sell
24,368
-500
-2% -$121K 0.82% 36
2019
Q2
$6.07M Buy
24,868
+70
+0.3% +$16.8K 0.91% 33
2019
Q1
$6.13M Buy
24,798
+47
+0.2% +$12K 0.92% 29
2018
Q4
$6.17M Sell
24,751
-5
-0% -$1.32K 1.01% 22
2018
Q3
$6.59M Sell
24,756
-60
-0.2% -$15.6K 0.93% 28
2018
Q2
$6.09M Buy
24,816
+85
+0.3% +$20.4K 0.89% 25
2018
Q1
$5.29M Buy
24,731
+540
+2% +$123K 0.79% 29
2017
Q4
$5.33M Sell
24,191
-15
-0.1% -$3.18K 0.74% 32
2017
Q3
$4.74M Sell
24,206
-51
-0.2% -$9.85K 0.69% 33
2017
Q2
$4.5M Sell
24,257
-390
-2% -$68.4K 0.69% 32
2017
Q1
$4.04M Sell
24,647
-150
-0.6% -$24.6K 0.6% 38
2016
Q4
$3.55M Hold
24,797
0.59% 41
2016
Q3
$3.55M Buy
24,797
+75
+0.3% +$10.5K 0.59% 41
2016
Q2
$3.49M Buy
24,722
+25
+0.1% +$3.33K 0.6% 40
2016
Q1
$3.18M Sell
24,697
-78
-0.3% -$9.23K 0.57% 42
2015
Q4
$2.92M Buy
24,775
+1,475
+6% +$172K 0.52% 42
2015
Q3
$2.7M Buy
23,300
+3,245
+16% +$388K 0.55% 45
2015
Q2
$2.45M Buy
20,055
+1,865
+10% +$221K 0.45% 53
2015
Q1
$2.15M Buy
+18,190
New +$2.02M 0.38% 57
2014
Q4
Sell
-1,510
Closed -$130K 179
2014
Q3
$130K Buy
+1,510
New +$128K 0.02% 156

Other funds holding UNH

Folger Nolan Fleming Douglas Capital Management's UNH Position: Q2 2026 in Review

Folger Nolan Fleming Douglas Capital Management reduced its UnitedHealth (UNH) stake by 0.67% in Q2 2026, selling an estimated $74.9K and leaving 29,919 shares worth $12.4M. The position accounts for 1.02% of the portfolio, ranked #29.

Folger Nolan Fleming Douglas Capital Management first reported a position in UNH in Q3 2014 and has held it in 47 quarters since. The position peaked at $14.5M in Q3 2024. 1,679 funds tracked by Wall St. Rank hold UNH as of Q2 2026.

  • Folger Nolan Fleming Douglas Capital Management held 29,919 shares of UnitedHealth worth $12.4M as of Q2 2026.
  • Folger Nolan Fleming Douglas Capital Management sold 202 UnitedHealth shares in Q2 2026, an estimated $74.9K.
  • UnitedHealth made up 1.02% of Folger Nolan Fleming Douglas Capital Management's portfolio in Q2 2026, its #29 holding.
  • Folger Nolan Fleming Douglas Capital Management first reported a position in UnitedHealth in Q3 2014 and has held it in 47 quarters since.
  • Folger Nolan Fleming Douglas Capital Management's UnitedHealth position peaked at $14.5M in Q3 2024.
  • 1,679 funds tracked by Wall St. Rank held UnitedHealth as of Q2 2026.

Based on Folger Nolan Fleming Douglas Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.